UK markets closed

Stayble Therapeutics AB (publ) (STABL.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
0.2755+0.0025 (+0.92%)
At close: 03:57PM CEST
Currency in SEK

Valuation measures4

Market cap (intra-day) 8.66M
Enterprise value -12.63M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.38
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.57

Trading information

Stock price history

Beta (5Y monthly) -0.07
52-week change 3-80.36%
S&P500 52-week change 325.77%
52-week high 36.4200
52-week low 30.1900
50-day moving average 30.2554
200-day moving average 31.6866

Share statistics

Avg vol (3-month) 3161.99k
Avg vol (10-day) 3207.45k
Shares outstanding 531.72M
Implied shares outstanding 631.72M
Float 829.41M
% held by insiders 119.33%
% held by institutions 120.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-73.44%
Return on equity (ttm)-149.34%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-23.74M
Diluted EPS (ttm)-1.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.08M
Total cash per share (mrq)0.44
Total debt (mrq)850k
Total debt/equity (mrq)5.15%
Current ratio (mrq)3.69
Book value per share (mrq)0.52

Cash flow statement

Operating cash flow (ttm)-23.54M
Levered free cash flow (ttm)-15.02M